Showing results (241-250 of 302) with videos related to

Sort By:
Pageof 31
Redox Biology|February 8, 2018
In situ generation, metabolism and immunomodulatory signaling actions of nitro-conjugated linoleic acid in a murine model of inflammationLuis Villacorta, Lucia Minarrieta, Sonia R Salvatore, et al.
Cardiovascular Drugs and Therapy|July 17, 2020
Suppression of Vascular Macrophage Activation by Nitro-Oleic Acid and its Implication for Abdominal Aortic Aneurysm TherapyYang Zhao, Ziyi Chang, Guizhen Zhao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 18, 2012
Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbitsYao Wang, Manabu Niimi, Kazutoshi Nishijima, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 22, 2017
Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in RabbitsJifeng Zhang, Manabu Niimi, Dongshan Yang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 14, 2020
BAF60a Deficiency in Vascular Smooth Muscle Cells Prevents Abdominal Aortic Aneurysm by Reducing Inflammation and Extracellular Matrix DegradationZiyi Chang, Guizhen Zhao, Yang Zhao, et al.
Circulation|February 18, 2009
Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulationJui-Sheng Wu, Wai-Mui Cheung, Yau-Sheng Tsai, et al.
Science Translational Medicine|February 8, 2023
Metabolic reprogramming by immune-responsive gene 1 up-regulation improves donor heart preservation and functionIenglam Lei, Wei Huang, Pierre Emmanuel Noly, et al.
Cell Reports|September 28, 2023
Myeloid BAF60a deficiency alters metabolic homeostasis and exacerbates atherosclerosisYang Zhao, Yuhao Liu, Guizhen Zhao, et al.
The Journal of Biological Chemistry|November 1, 2011
Identification and mechanism of 10-carbon fatty acid as modulating ligand of peroxisome proliferator-activated receptorsRaghu R V Malapaka, SokKean Khoo, Jifeng Zhang, et al.
JCI Insight|February 15, 2024
Sotagliflozin attenuates liver-associated disorders in cystic fibrosis rabbitsXiubin Liang, Xia Hou, Mohamad Bouhamdan, et al.
Pageof 31